GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

Patients with chronic kidney disease who had hypertension and diabetes and received insulin therapy showed a 35% lower risk ...

Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...

Hypercortisolism is tied to multiple cardio-renal-metabolic disorders, making cortisol level screening an important part of patient monitoring, according to speakers at the Heart in Diabetes CME ...

Early trials found that both garadacimab and sebetralstat were safe when used in patients living with hereditary angioedema, ...